{"id":"NCT03624127","sponsor":"Bristol-Myers Squibb","briefTitle":"Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis","officialTitle":"A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-07","primaryCompletion":"2020-09-02","completion":"2020-09-02","firstPosted":"2018-08-09","resultsPosted":"2023-01-30","lastUpdate":"2023-01-30"},"enrollment":666,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"BMS-986165","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Apremilast","otherNames":[]}],"arms":[{"label":"BMS-986165","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Apremilast","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.","primaryOutcome":{"measure":"The Number of Participants With a Static Physician's Global Assessment (sPGA) Score of 0 or 1 in Participants Receiving BMS-986165 Compared to Placebo at Week 16 (sPGA 0/1)","timeFrame":"Week 16","effectByArm":[{"arm":"BMS-986165","deltaMin":178,"sd":null},{"arm":"Placebo","deltaMin":12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":165,"countries":["United States","Canada","China","Germany","Japan","Poland","Russia","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["40113724","40066907","39602111","39080153","38907877","37150952"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/investigator-inquiry-form.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":332},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Diarrhoea","Nausea"]}}